Peripheral blood stem cell transplants are safer and easier for the donor and with contemporary graft-vs-host disease (GVHD) prophylaxis, they don't appear to pose any additional GVHD risk for the ...

We hypothesized that post-transplant cyclophosphamide (PTCy) based graft versus host disease (GVHD) prophylaxis would improve outcomes for HSCT recipients using peripheral blood stem cells (PBSCs) ...

Relapsed/refractory peripheral and cutaneous T-cell lymphomas (R/R PTCL and CTCL) are aggressive blood cancers that often ...

Less emphasis on full HLA matching means clinicians can find an appropriate donor for any patient, says Antonio Jimenez ...

A Little Rock church held a stem cell drive Saturday in hopes of finding a potential donor for a member with a rare type of ...

Scientists at ETH Zurich have broken new ground by generating over 400 types of nerve cells from stem cells in the lab, far ...

Autografting with peripheral blood stem cells (PBSC) has largely replaced autologous bone marrow transplantation (BMT). PBSC may be preferred because of the easier collection and faster ...

Nerve cells are not just nerve cells. Depending on how finely we distinguish, there are several hundred to several thousand ...

A new study shows that patients achieve good outcomes with a partial match drawn from the national public registry of donors when they are treated with the immune-suppressing drug cyclophosphamide.

Antonio Jimenez Jimenez, MD, discusses the ACCESS study using HLA-mismatched unrelated donors for peripheral blood and bone marrow stem cell transplants.

Relapsed/refractory peripheral and cutaneous T-cell lymphomas (R/R PTCL and CTCL) are aggressive blood cancers that often ...

Antonio Jimenez Jimenez, MD, discusses the ACCESS trial of PTCy-based GVHD prophylaxis after mismatched unrelated donor stem ...